1. Home
  2. IMNM vs BWIN Comparison

IMNM vs BWIN Comparison

Compare IMNM & BWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immunome Inc.

IMNM

Immunome Inc.

N/A

Current Price

$23.85

Market Cap

2.5B

Sector

Health Care

ML Signal

N/A

Logo The Baldwin Insurance Group Inc.

BWIN

The Baldwin Insurance Group Inc.

N/A

Current Price

$32.20

Market Cap

3.0B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
IMNM
BWIN
Founded
2006
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Specialty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
3.0B
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
IMNM
BWIN
Price
$23.85
$32.20
Analyst Decision
Strong Buy
Buy
Analyst Count
10
7
Target Price
$32.80
$30.43
AVG Volume (30 Days)
884.8K
2.2M
Earning Date
05-08-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
51.40
N/A
EPS
N/A
N/A
Revenue
$6,941,000.00
$1,504,884,000.00
Revenue This Year
N/A
$36.36
Revenue Next Year
$1,127.34
$10.82
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.34
52 Week Low
$8.93
$15.88
52 Week High
$30.06
$32.59

Technical Indicators

Market Signals
Indicator
IMNM
BWIN
Relative Strength Index (RSI) 35.85 62.04
Support Level $23.67 $25.11
Resistance Level $25.07 N/A
Average True Range (ATR) 1.00 1.06
MACD -0.59 -0.02
Stochastic Oscillator 6.86 93.86

Price Performance

Historical Comparison
IMNM
BWIN

About IMNM Immunome Inc.

Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.

About BWIN The Baldwin Insurance Group Inc.

The Baldwin Insurance Group Inc is an insurance distribution company operating in the United States. The company provides commercial risk management, employee benefits, private risk management, and personal insurance solutions. It operates through three segments: Insurance Advisory Solutions, which focuses on commercial risk management and employee benefits; Underwriting, Capacity & Technology Solutions, which includes managing general agency operations, reinsurance brokerage, captive management, and technology-enabled insurance products; and Mainstreet Insurance Solutions, which offers personal, commercial, and life and health insurance products through community-based distribution channels.

Share on Social Networks: